DRUG REPURPOSING

Clinical trials for DRUG REPURPOSING explained in plain language.

Never miss a new study

Get alerted when new DRUG REPURPOSING trials appear

Sign up with your email to follow new studies for DRUG REPURPOSING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New cocktail aims to outsmart Drug-Resistant liver cancer

Disease control Not yet recruiting

This study tests a combination of three drugs—ivarmacitinib, camrelizumab, and apatinib—in 65 people with advanced liver cancer that has stopped responding to initial immunotherapy. The goal is to see if this triple therapy can shrink tumors or slow disease progression. Participa…

Matched conditions: DRUG REPURPOSING

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

DRUG REPURPOSING

Get alerted when new DRUG REPURPOSING trials appear

New cocktail aims to outsmart Drug-Resistant liver cancer